Department of Obstetrics and Gynecology, Seoul St, Mary's Hospital, The Catholic University of Korea, Banpodaero, Seocho-Gu, Seoul, Korea.
World J Surg Oncol. 2014 Oct 15;12:314. doi: 10.1186/1477-7819-12-314.
Large cell neuroendocrine carcinoma (LCNC) of the ovary, or ovarian undifferentiated non-small cell carcinoma of neuroendocrine type, is a rare entity that is frequently associated with ovarian surface epithelial tumors. Few cases have been reported in the literature. LCNC is an aggressive tumor with tendency to present at advanced stages and to cause death after a short postoperative duration. We report three cases of LCNC diagnosed histopathologically. Immunohistochemically, the tumor cells were positive for chromogranin A, NSE, CD56, and pancytokeratin. The patients were treated postoperatively with combination chemotherapy. Due to the rarity of LCNC, the general consensus on standard therapy is not established. Although most patients are at stage I, the biological aggressiveness and poor prognosis of the tumors have been reported in previous reports despite extensive surgery and chemotherapy.
卵巢大细胞神经内分泌癌(LCNC),又称卵巢神经内分泌型未分化非小细胞癌,是一种罕见的实体瘤,常与卵巢表面上皮性肿瘤相关。文献中报道的病例较少。LCNC 是一种侵袭性肿瘤,常表现为晚期,术后短期内即导致死亡。我们报告了 3 例经组织病理学诊断为 LCNC 的病例。免疫组化结果显示,肿瘤细胞对嗜铬粒蛋白 A、NSE、CD56 和细胞角蛋白均呈阳性。患者术后接受联合化疗。由于 LCNC 较为罕见,目前尚未就标准治疗达成共识。尽管大多数患者处于Ⅰ期,但既往报道显示,尽管进行了广泛的手术和化疗,肿瘤仍具有较强的生物学侵袭性和较差的预后。